LBPH Insider Trading Activity and SEC Form 4 Filings
LBPH insider trading summary
No open-market insider purchases or sales of Longboard Pharmaceuticals, Inc. (LBPH) have been reported on SEC Form 4 in the past 12 months.
Latest LBPH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 15, 2024 | Randall Kaye | CMO | Sell | $984K (16,667 @ $59.03) |
| Sep 16, 2024 | Randall Kaye | CMO | Sell | $40K (1,200 @ $33.12) |
| Sep 16, 2024 | Randall Kaye | CMO | Sell | $289K (9,366 @ $30.89) |
| Sep 16, 2024 | Randall Kaye | CMO | Sell | $134K (4,200 @ $31.81) |
| Sep 16, 2024 | Randall Kaye | CMO | Sell | $65K (1,900 @ $34.04) |
| Aug 12, 2024 | Randall Kaye | CMO | Sell | $362K (10,476 @ $34.55) |
| Aug 12, 2024 | Randall Kaye | CMO | Sell | $217K (6,191 @ $35.03) |
| Jun 25, 2024 | Randall Kaye | CMO | Sell | $2K (100 @ $20.87) |
| Jan 25, 2024 | Arena Pharmaceuticals Inc | Insider | Sell | $96.5M (3,978,540 @ $24.25) |
| Jan 23, 2024 | Randall Kaye | CMO | Buy | $2K (100 @ $24.82) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.